Skip to main content
. 2021 Jul 20;13(7):1099. doi: 10.3390/pharmaceutics13071099

Figure 3.

Figure 3

Molecular structures of: (A) naproxen, (B) lornoxicam, (C) oxaprozin, (D) zaltoprofen, (E) etodolac, (F) glyburide, (G) repaglinide, (H) nateglinide, (I) cefixime and (J) rifampicin.